Improving translation success of cell‐based therapies in orthopaedics |
| |
| Authors: | Jennifer J. Bara Marietta Herrmann Christopher H. Evans Theodore Miclau Anthony Ratcliffe R. Geoff Richards |
| |
| Affiliation: | 1. AO Research Institute Davos, Clavadelerstrasse 8, Switzerland;2. Rehabilitation Medicine Research Center, Mayo Clinic, Rochester;3. Department of Orthopaedic Surgery, University of California, San Francisco/San Francisco General Hospital, Orthopaedic Trauma Institute, San Francisco;4. Synthasome Inc., 2658 Del Mar Heights Road, California |
| |
| Abstract: | There is a clear discrepancy between the growth of cell therapy and tissue engineering research in orthopaedics over the last two decades and the number of approved clinical therapies and products available to patients. At the 2015 annual meeting of the Orthopaedic Research Society, a workshop was held to highlight important considerations from the perspectives of an academic scientist, clinical researcher, and industry representative with the aim of helping researchers to successfully translate their ideas into clinical and commercial reality. Survey data acquired from workshop participants indicated an overall positive opinion on the future potential of cell‐based therapies to make a significant contribution to orthopaedic medicine. The survey also indicated an agreement on areas requiring improvement in the development of new therapies, specifically; increased support for fundamental research and education and improved transparency of regulatory processes. This perspectives article summarises the content and conclusions of the workshop and puts forward suggestions on how translational success of cell‐based therapies in orthopaedics may be achieved. © 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:17–21, 2016. |
| |
| Keywords: | translation cell‐therapy stem cell |
|
|
